SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: vestor who wrote (642)3/10/1998 8:28:00 PM
From: Shake-Man  Read Replies (1) of 1837
 
Premarin is the biggest selling drug in the U.S. With the majority of people on some form of HMO or prescription insurance, they will be "forced" to get the drug that is on the HMO's formulary. And as we all know, HMO's and insurance companies have one goal above all...save money. So if Parke Davis can convince HMO's and ins. companies to put their conj. estrogen product on formulary over Premarin for a lower price, then Parke Davis, Duramed, and we the stockholders can open up our pockets and let the money start pouring in. Now if the FDA would only hurry their butts up...
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext